Evidence map›Paper›PMID 25750932›Full record

ArticleCellular and molecular gastroenterology and hepatology2015

A novel role for KLF14 in T regulatory cell differentiation.

Olga F Sarmento, Phyllis A Svingen, Yuning Xiong, Ramnik J Xavier, Dermot McGovern, Thomas C Smyrk, Konstantinos A Papadakis, Raul A Urrutia, William A Faubion

Open access · bronzeAbstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 58 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. CD4Journal of the American Heart Association · 2021
    Article
  13. Transcription Factor KLF14 and Metabolic Syndrome.Frontiers in cardiovascular medicine · 2020
    Review
  14. Article
  15. Overexpression of KLF14 protects against immune-mediated hepatic injury in mice.Laboratory investigation; a journal of technical methods and pathology · 2019
    Article
  16. Article
  17. Article
  18. Hypermethylation ofOxidative medicine and cellular longevity · 2018
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Olga F SarmentoEpigenetics and Chromatin Dynamics Laboratory, Division of Gastroenterology and Hepatology and Translational Epigenomic Program, Center for Individualized Medicine (CIM), Mayo Clinic Rochester.
Phyllis A SvingenEpigenetics and Chromatin Dynamics Laboratory, Division of Gastroenterology and Hepatology and Translational Epigenomic Program, Center for Individualized Medicine (CIM), Mayo Clinic Rochester.
Yuning XiongEpigenetics and Chromatin Dynamics Laboratory, Division of Gastroenterology and Hepatology and Translational Epigenomic Program, Center for Individualized Medicine (CIM), Mayo Clinic Rochester.
Ramnik J XavierMassachusetts General Hospital, HMS, Boston, MA.
Dermot McGovernCedars Sinai Hospital, Los Angeles, CA.
Thomas C SmyrkLaboratory and Medical Pathology, Mayo Clinic, Rochester, MN 55905.
Konstantinos A PapadakisEpigenetics and Chromatin Dynamics Laboratory, Division of Gastroenterology and Hepatology and Translational Epigenomic Program, Center for Individualized Medicine (CIM), Mayo Clinic Rochester.
Raul A UrrutiaEpigenetics and Chromatin Dynamics Laboratory, Division of Gastroenterology and Hepatology and Translational Epigenomic Program, Center for Individualized Medicine (CIM), Mayo Clinic Rochester.
William A FaubionEpigenetics and Chromatin Dynamics Laboratory, Division of Gastroenterology and Hepatology and Translational Epigenomic Program, Center for Individualized Medicine (CIM), Mayo Clinic Rochester.
Mayo Clinic · USCedars-Sinai Medical Center · USMassachusetts General Hospital · USWinnMed · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
ZINC FINGER GENES AND PANCREATIC CELL GROWTHR01DK052913 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI LOMBERK, GWEN, URRUTIA, RAUL A. · 1998 to 2023
$7.0M
KLF10 regulates colitis through mediating TGFb induction of FOXP3 in Treg cells.R01AI089714 · NIAID · MAYO CLINIC ROCHESTER · PI FAUBION, WILLIAM A · 2011 to 2025
$6.3M
Novel Experimental Therapeutics for Pancreatic CancerR01CA178627 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI LOMBERK, GWEN · 2014 to 2018
$1.6M
KLF10 regulates colitis through mediating TGFb induction of FOXP3 in Treg cells.R56AI089714 · NIAID · MAYO CLINIC ROCHESTER · PI FAUBION, WILLIAM A · 2010 to 2010
$394k
NCI NIH HHS R01 CA178627NIAID NIH HHS R01 AI089714NIAID NIH HHS R56 AI089714NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK052913
6 · The paper itself

Abstract

BACKGROUND AND

aimsKLF proteins function as epigenetic reprogramming factors during cell differentiation in many cell populations and in engineered iPS cells. In this study, we determined KLF14 function in the regulation of FOXP3, a transcription factor critical for Treg cell differentiation.

methodsWe studied the effects of KLF14 on FOXP3 expression at the level of the protein and mRNA. We evaluated the functional relevance of KLF14 to FOXP3

resultsKLF14, induced upon activation of naïve CD4

conclusionsThese results outline a novel mechanism by which KLF14 regulates Treg cell differentiation via chromatin remodeling at the FOXP3 TSDR. To our knowledge, this is the first evidence supporting a role for KLF14 in maintaining the differentiated state of Treg cells and outlines a potential mechanism to modify the expression of immune genes, such as FOXP3, which are critical to T cell fate.

Indexed as

FOXP3H3K9Me3KLF14T regulatory cellTSDR

Identifiers

PMID25750932
PMCPMC4349492
OpenAlexW1993178531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.